Eric Chatelain

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens

P. Uchil, G. Gendron-Lepage, W. Mothes, 2024, iScience.

Further preclinical characterization of molnupiravir against SARS-CoV-2 : Antiviral activity determinants and viral genome alteration patterns.

F. Touret, A. Nougairède, C. Laprie, 2024, Heliyon.

Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay

M. Zrein, Ivan Scandale, Ursula Saade, 2024, Nature communications.